| Product NDC: | 55154-2353 |
| Proprietary Name: | Metoclopramide |
| Non Proprietary Name: | METOCLOPRAMIDE HYDROCHLORIDE |
| Active Ingredient(s): | 5 mg/mL & nbsp; METOCLOPRAMIDE HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-2353 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073118 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090922 |
| Package NDC: | 55154-2353-5 |
| Package Description: | 5 VIAL in 1 BAG (55154-2353-5) > 2 mL in 1 VIAL |
| NDC Code | 55154-2353-5 |
| Proprietary Name | Metoclopramide |
| Package Description | 5 VIAL in 1 BAG (55154-2353-5) > 2 mL in 1 VIAL |
| Product NDC | 55154-2353 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20090922 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |